suggest
multipl
sclerosi
ms
develop
patient
genet
predispos
demyelin
diseas
follow
exposur
environment
factor
strike
epidemiolog
evid
suggest
environment
factor
play
role
develop
ms
factor
includ
geograph
variat
preval
alter
suscept
follow
reloc
discord
clinic
diseas
major
monozygot
twin
howev
possibl
defin
exactli
environment
factor
associ
genet
predisposit
result
develop
clinic
diseas
forefront
list
possibl
environment
factor
might
exacerb
develop
sever
ms
viral
infect
fact
infect
central
nervou
system
cn
wide
use
mous
model
experiment
autoimmun
encephalomyel
eae
consist
reproduc
symptomolog
human
diseas
coronaviru
murin
hepat
viru
also
shown
caus
demyelin
diseas
cn
recent
studi
suggest
associ
infect
human
gammaherpesviru
ebv
risk
ms
one
prospect
epidemiolog
studi
antibodi
level
elev
women
ms
suggest
ebv
might
involv
etiolog
autoimmun
diseas
recent
work
support
previou
studi
demonstr
increas
antibodi
titer
patient
ms
addit
particular
cell
receptor
ms
patient
recogn
peptid
peptid
deriv
ebv
protein
studi
suggest
mechan
molecular
mimicri
might
facilit
develop
ms
time
ebv
infect
direct
relationship
viral
infect
develop
ms
difficult
prove
relianc
human
autopsi
materi
materi
taken
blood
spinal
fluid
circumv
limit
rodent
model
ms
develop
contribut
greatli
understand
cellular
molecular
event
occur
demyelin
diseas
cn
relaps
eae
diseas
character
inflamm
demyelin
within
cn
sjl
mous
often
use
model
diseas
activ
immun
immunodomin
peptid
proteolipid
protein
plp
induc
relaps
eae
mice
eae
also
induc
passiv
transfer
encephalitogen
lymphocyt
certain
strain
mice
rat
passiv
transfer
helper
cell
obviat
need
activ
immun
mice
allow
studi
event
develop
eae
passiv
transfer
encephalitogen
lymphocyt
lewi
rat
provid
reproduc
form
eae
use
investig
acut
form
diseas
present
studi
eae
sjl
mice
eae
lewi
rat
use
model
address
whether
infect
murin
could
exacerb
clinic
diseas
use
mous
model
ebv
human
infect
rodent
model
studi
gammaherpesvirus
studi
present
rodent
expos
infect
undergo
eae
score
sever
diseas
result
studi
clearli
demonstr
infect
murin
gammaherpesviru
exacerb
clinic
symptom
associ
eae
without
substanti
entri
viru
cn
follow
immun
sjl
mice
plp
peptid
neurodegen
diseas
ensu
follow
score
clinic
symptom
shown
fig
close
squar
day
follow
initi
immun
group
sjl
mice
previous
expos
began
show
sign
cn
diseas
peak
day
kinet
magnitud
respons
similar
previous
report
other
contrast
clinic
score
sjl
mice
infect
dramat
differ
kinet
magnitud
fig
close
circl
compar
group
mice
expos
clinic
symptom
infect
mice
began
day
earlier
result
mice
moribund
day
clearli
mice
infect
immun
plp
peptid
demonstr
mark
exacerb
clinic
symptom
compar
control
control
demonstr
natur
eae
induct
sever
group
mice
use
includ
group
mice
infect
given
complet
freund
adjuv
alon
given
pertussi
toxin
alon
immun
irrelev
peptid
none
mice
control
group
show
neurolog
deficit
cours
studi
eg
fig
close
triangl
addit
assess
clinic
diseas
decreas
bodi
weight
follow
mice
expos
infect
immun
induc
eae
fig
show
earli
exacerb
weight
loss
mice
infect
viru
compar
mice
expos
addit
histolog
analys
perform
indic
level
inflamm
spinal
cord
cerebellum
infect
versu
uninfect
mice
undergo
eae
day
group
mice
kill
spinal
cord
cerebellum
stain
score
infiltr
leukocyt
mice
infect
significantli
p
inflamm
mean
score
mice
expos
mean
score
wherea
control
mice
infect
immun
detect
inflamm
cn
mean
score
one
possibl
explan
exacerb
eae
would
replic
viru
within
cn
directli
caus
neuron
death
caus
destruct
inflammatori
respons
gain
access
cn
clinic
eae
presenc
viru
difficult
detect
address
whether
present
cn
sensit
nest
pcr
procedur
perform
detect
presenc
dna
encod
spleen
spinal
cord
infect
mice
infect
mice
undergo
clinic
eae
fig
show
result
one
pcr
viral
genom
easili
detect
peripher
lymphoid
organ
ie
spleen
spinal
cord
infect
mice
true
even
nest
pcr
perform
cycl
wherea
viral
dna
sequenc
abund
spleen
use
pcr
cycl
although
qualit
differ
viral
genom
presenc
cn
versu
peripher
lymphoid
organ
suggest
minim
viral
replic
latenc
occur
cn
directli
address
presenc
replic
viru
spleen
cn
infect
mice
undergo
clinic
eae
assay
perform
assay
consist
fail
demonstr
presenc
lytic
viru
tissu
homogen
brain
spinal
cord
infect
mice
undergo
clinic
eae
regardless
chosen
analysi
addit
assay
use
quantifi
latent
viru
present
spleen
infect
sjl
mice
fig
show
similar
number
infecti
center
splenic
leukocyt
mice
whether
eae
induc
howev
unabl
detect
latent
cell
isol
spinal
cord
mice
fig
taken
togeth
result
fig
strongli
argu
presenc
signific
viral
burden
peripher
tissu
cn
passiv
transfer
encephalitogen
lymphocyt
lewi
rat
also
use
model
investig
abil
gammaherpesviru
exacerb
autoimmun
diseas
cn
howev
first
import
demonstr
strain
suscept
viral
infect
sinc
report
date
demonstr
infect
rat
follow
intranas
inocul
group
lewi
rat
unit
pfu
viru
characterist
splenomegali
leukocytosi
establish
latent
viru
observ
infect
rat
typic
spleen
infect
rat
increas
size
compar
rat
expos
mg
versu
mg
respect
splenic
leukocyt
number
peak
day
fig
presenc
viral
genom
easili
detect
rat
use
nest
pcr
fig
amplifi
product
absent
control
rat
addit
viral
latenc
establish
rat
highest
level
viral
burden
observ
day
fig
previous
observ
laboratori
other
infecti
center
due
presenc
latent
viru
lytic
replic
viru
mechan
disrupt
splenocyt
produc
pfu
incub
permiss
monolay
cell
taken
togeth
result
demonstr
murin
infect
rat
induc
symptom
diseas
similar
seen
mice
hallmark
leukocytosi
establish
latenc
establish
characterist
infect
lewi
rat
induc
eae
anim
use
passiv
transfer
encephalitogen
lymphocyt
studi
group
rat
expos
infect
intranas
infect
encephalitogen
lymphocyt
specif
myelin
basic
protein
given
intraven
rat
score
daili
develop
clinic
symptom
consist
rat
infect
increas
clinic
score
compar
anim
expos
fig
note
signific
differ
clinic
eae
score
group
untreat
rat
compar
rat
treat
group
receiv
encephalitogen
lymphocyt
eg
fig
experi
control
demonstr
natur
eae
induct
sever
group
rat
use
includ
group
infect
receiv
encephalitogen
lymphocyt
rat
given
normal
lymphocyt
eg
fig
experi
detect
neurolog
symptom
observ
control
group
addit
assess
clinic
diseas
decreas
bodi
weight
follow
rat
expos
infect
administ
encephalitogen
lymphocyt
induc
eae
fig
show
increas
weight
loss
two
compar
rat
expos
sever
clinic
symptom
manipul
lewi
rat
model
vari
number
encephalitogen
lymphocyt
inject
therefor
studi
group
rat
expos
infect
given
encephalitogen
lymphocyt
fig
show
anim
given
higher
number
encephalitogen
lymphocyt
progress
rapidli
moribund
state
howev
rat
infect
higher
initi
score
anim
expos
fig
thu
regardless
protocol
use
abil
exacerb
clinic
diseas
consist
use
protocol
allow
rat
recov
fig
use
protocol
rat
rapidli
progress
moribund
state
fig
show
rat
significantli
higher
clinic
score
eae
sjl
mous
fig
lewi
rat
fig
model
experiment
design
demonstr
exacerb
eae
rodent
begin
leukocytosi
clinic
symptom
progress
howev
upon
resolut
diseas
splenomegali
resolv
remain
latent
leukocyt
question
whether
rat
latent
infect
also
increas
clinic
score
follow
passiv
administr
encephalitogen
cell
studi
group
rat
expos
infect
allow
recov
acut
infect
splenomegali
time
rat
viral
genom
present
latent
viru
splenic
leukocyt
detect
viru
tissu
homogen
day
encephalitogen
lymphocyt
given
intraven
rat
score
daili
develop
clinic
symptom
consist
rat
latent
infect
increas
clinic
score
compar
anim
expos
fig
question
whether
caus
exacerb
eae
might
presenc
signific
viral
infect
within
cn
present
replic
viru
might
directli
result
neuron
damag
caus
deleteri
inflammatori
respons
gain
access
cn
clinic
eae
presenc
viru
would
difficult
detect
address
possibl
sensit
nest
pcr
procedur
perform
detect
presenc
dna
encod
spleen
spinal
cord
infect
rat
infect
rat
undergo
clinic
eae
fig
show
result
one
pcr
viral
genom
easili
detect
peripher
lymphoid
organ
ie
spleen
spinal
cord
infect
rat
nest
pcr
perform
cycl
dna
could
detect
spinal
cord
wherea
viral
dna
sequenc
abund
spleen
use
pcr
cycl
similar
result
found
nest
pcr
perform
use
frontal
cortex
cerebellum
data
shown
although
qualit
differ
presenc
cn
versu
peripher
lymphoid
organ
suggest
minim
viral
replic
occur
cn
addit
assay
consist
fail
demonstr
presenc
lytic
viru
tissu
homogen
brain
spinal
cord
infect
rat
undergo
clinic
eae
regardless
chosen
analysi
togeth
result
strongli
suggest
exacerb
eae
lewi
rat
model
due
signific
replic
viru
cn
recent
epidemiolog
studi
previou
investig
postul
associ
develop
andor
sever
ms
infect
gammaherpesviru
ebv
necess
reli
analys
use
antibodi
patient
sera
cn
tissu
obtain
autopsi
provid
intrigu
correl
definit
result
present
studi
two
differ
rodent
model
eae
use
assess
abil
gammaherpesviru
infect
rodent
exacerb
neurolog
symptom
use
eae
sjl
mice
fig
eae
lewi
rat
fig
overal
result
qualit
rodent
infect
significantli
clinic
diseas
rat
expos
limit
abil
enter
cn
fig
lack
replic
latent
viru
fig
provid
import
focu
begin
understand
mechan
involv
exacerb
eae
certain
virus
includ
theiler
viru
murin
hepat
viru
inject
directli
cn
mice
caus
inflamm
demyelin
resembl
diseas
thu
preced
certain
virus
replic
within
cn
induc
patholog
clinic
symptomolog
describ
eae
howev
highli
unlik
base
result
present
result
other
directli
invad
cn
signific
extent
follow
peripher
infect
numer
laboratori
use
model
investig
great
detail
pathophysiolog
gammaherpesviru
infect
none
report
neurolog
symptom
acut
latent
phase
thu
infect
peripheri
result
eae
discern
clinic
symptomolog
addit
viral
genomeswer
found
within
cn
infect
rodent
even
sensit
nest
pcr
procedur
use
fig
lack
signific
viral
burden
cn
argu
strongli
destruct
neuron
glial
cell
enter
cn
signific
extent
mechan
requir
exacerb
eae
must
occur
peripher
tissu
recent
discoveri
suggest
intrigu
possibl
understand
gammaherpesvirus
might
contribut
sever
autoimmun
diseas
molecular
mimicri
viral
protein
sequenc
encephalitogen
epitop
propos
gammaherpesviru
ebv
one
studi
found
viral
protein
could
activ
lymphocyt
specif
myelin
basic
protein
sjl
mice
anoth
recent
studi
found
particular
cell
receptor
ms
patient
recogn
peptid
peptid
deriv
ebv
protein
theoret
molecular
mimicri
could
lead
exagger
induct
activ
andor
differenti
encephalitogen
cell
therebi
augment
develop
sever
ms
howev
investig
contribut
molecular
mimicri
develop
autoimmun
diseas
ebv
infect
challeng
problem
inher
limit
human
experiment
fact
encephalitogen
epitop
might
differ
rodent
men
make
difficult
conclus
prove
molecular
mimicri
mechan
ms
fortun
genom
sequenc
therefor
possibl
exploit
inform
identifi
like
encephalitogen
epitop
importantli
use
experiment
model
definit
prove
whether
sequenc
involv
induc
increas
sever
eae
second
mechan
could
contribut
observ
exacerb
eae
would
one
depend
upon
antigen
epitop
gammaherpesviru
caus
uniqu
dysregul
host
immun
respons
character
immunolog
disson
expans
b
lymphocyt
occur
phase
diseas
larg
specif
viral
antigen
fact
lymphocyt
infect
therefor
mechan
lead
cell
expans
must
requir
interact
input
cell
popul
possibl
mechan
involv
dysregul
host
lymphocyt
respons
follow
viral
infect
also
involv
augment
number
activ
encephalitogen
lymphocyt
present
develop
eae
note
howev
necessari
rat
experienc
peak
leukocytosi
exacerb
clinic
eae
fig
rat
latent
low
level
replic
viru
littl
splenomegali
rel
normal
number
percentag
lymphocyt
encephalitogen
lymphocyt
passiv
transfer
rat
exacerb
clinic
score
still
observ
result
signific
sinc
essenti
patient
develop
ms
latent
ebv
infect
acut
mononucleosi
ongo
studi
aim
defin
whether
encephalitogen
event
result
develop
eae
also
serv
stimulu
reactiv
latent
product
peripher
infect
case
suppress
viral
replic
prior
clinic
diseas
might
prove
effect
limit
sever
durat
damag
cn
highli
unlik
gammaherpesvirus
directli
caus
ms
eae
greater
world
popul
latent
infect
ebv
small
percentag
individu
develop
clinic
ms
therefor
assert
ebv
etiolog
agent
neurodegen
diseas
met
much
skeptic
like
possibl
could
help
explain
epidemiolog
experiment
data
would
role
ebv
environment
factor
may
exacerb
diseas
patient
rodent
predispos
develop
demyelin
whether
exacerb
involv
molecular
mimicri
dysregul
leukocyt
function
clear
howev
studi
present
clearli
demonstr
peripher
infect
capabl
augment
inflammatori
respons
cn
rodent
model
viral
infect
extrem
valuabl
dissect
mechan
respons
exacerb
autoimmun
diseas
propag
isol
previous
describ
intranas
inocul
perform
femal
sjl
mice
jackson
laboratori
bar
harbor
usa
femal
lewi
rat
charl
river
laboratori
wilmington
usa
previous
describ
group
sjl
mice
expos
infect
day
prior
initi
immun
protocol
immun
protocol
similar
previous
report
involv
initi
inject
plp
peptid
emulsifi
complet
freund
adjuv
contain
mycobacteria
addit
mice
receiv
ng
bordetella
pertussi
toxin
research
biochem
intern
natick
usa
time
immun
day
mice
expos
infect
code
assess
daili
develop
eae
blind
fashion
use
follow
scale
evid
diseas
limp
tail
hind
limb
weak
limp
tail
hind
limb
weak
hind
limb
paralysi
moribund
sever
control
group
sjl
mice
infect
given
complet
freund
adjuv
alon
b
pertussi
toxin
alon
immun
irrelev
peptid
amino
acid
sequenc
hsfncggeffi
use
immun
scheme
ident
one
describ
passiv
administr
encephalitogen
lymphocyt
lewi
rat
use
second
rodent
model
eae
perform
previous
describ
encephalitogen
cell
line
establish
immun
lewi
rat
encephalitogen
peptid
myelin
basic
protein
previous
describ
group
lewi
rat
untreat
expos
infect
intranas
pfu
indic
time
eae
induc
inthes
rat
inject
indic
number
encephalitogen
lymphocyt
anim
expos
pfu
per
rat
use
control
rat
expos
rat
code
assess
daili
develop
eae
blind
fashion
use
followingscal
evid
diseas
flaccid
tail
hind
limb
paralysi
paralysi
moribund
confirm
natur
model
control
group
rat
receiv
leukocyt
expand
lewi
rat
presenc
dna
encod
spleen
spinal
cord
brain
rodent
detect
sensit
nest
pcr
protocol
previous
describ
presenc
lytic
viru
quantifi
previous
describ
use
assay
presenc
latent
viru
quantifi
use
assay
previous
describ
day
group
mice
infect
expos
viru
kill
section
spinal
cord
cerebellum
stain
use
hematoxylin
eosin
score
inflamm
previous
describ
signific
differ
mean
score
assess
use
valu
student
appropri
result
weredetermin
significantli
differ
p
